Crystalline N-methyl tryptamine derivatives
AssigneeCaamtech, Inc.
InventorAndrew R. Chadeayne
Life of this patent
Estimating the term…
Abstract
Crystalline N-methyl tryptamine derivatives, compositions containing those crystalline forms and their methods of use are disclosed. The crystalline N-methyl tryptamine derivatives according to the invention include crystalline N-methyl-N-propyltryptamine (MPT), crystalline N-methyl-N-isopropyltryptammonium fumarate (MiPT fumarate) and crystalline 4-hydroxy-N-methyl-N-isopropyltryptammonium fumarate monohydrate (HO-MiPT fumarate monohydrate).
Claims18
Crystalline N-methyl-N-propyltryptamine (MPT) characterized by one or more of:
- an orthorhombic, Pbca crystal system space group at a temperature of about 200 K;
- unit cell dimensions a=13.5715 (11) Å, b=12.4352(10) Å, c=15.1627(12) Å, at a temperature of about 200 K;
- or
- an x-ray powder diffraction (XRPD) pattern having peaks at 11.7, 13.4 and 19.4° 2θ±0.2° 2θ.
Crystalline N-methyl-N-isopropyltryptammonium fumarate (MiPT fumarate) characterized by one or more of:
- a monoclinic, P21/c crystal system space group at a temperature of about 200 K;
- unit cell dimensions a=9.852 (2) Å, b=12.789(2) Å, c=14.875 (3) Å, and β=106.932(7°) at a temperature of about 200 K;
- or
- an x-ray powder diffraction (XRPD) pattern having peaks at 11.9, 14.9 and 16.9° 2θ±0.2° 2θ.
Crystalline 4-hydroxy-N-methyl-N-isopropyltryptammonium fumarate monohydrate (HO-MiPT fumarate monohydrate) characterized by one or more of:
- a monoclinic, C2/c crystal system space group at a temperature of about 200 K;
- unit cell dimensions a=29.507 (3) Å, b=8.7445(8) Å, c=17.3659 (18) Å, and β=123.389(18°) at a temperature of about 200 K;
- or
- an x-ray powder diffraction (XRPD) pattern having peaks at 7.2, 13.4 and 18.0° 2θ±0.2° 2θ.
Dependencies are inferred from the claim text.